342 related articles for article (PubMed ID: 19200573)
41. Paracortical axillary sentinel lymph node ectopic breast tissue.
Zynger DL; McCallum JC; Everton MJ; Yeldandi AV; Susnik B
Pathol Res Pract; 2009; 205(6):427-32. PubMed ID: 19168294
[TBL] [Abstract][Full Text] [Related]
42. Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer.
Ehi K; Ishigami S; Masamoto I; Uenosono Y; Natsugoe S; Arigami T; Arima H; Kijima Y; Yoshinaka H; Yanagita S; Kozono T; Funasako Y; Maruyama I; Aikou T
Oncol Rep; 2008 Mar; 19(3):601-7. PubMed ID: 18288390
[TBL] [Abstract][Full Text] [Related]
43. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
Nakamura R; Sakakibara M; Nagashima T; Sangai T; Arai M; Fujimori T; Takano S; Shida T; Nakatani Y; Miyazaki M
Eur J Cancer; 2009 Aug; 45(12):2123-31. PubMed ID: 19398324
[TBL] [Abstract][Full Text] [Related]
44. Surgical management of the axilla: do intramammary nodes matter?
Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
[TBL] [Abstract][Full Text] [Related]
45. Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: initial experience and lessons learnt in establishing a new practice.
Pathmanathan N; Jones W; Salisbury E; Bilous M
Pathology; 2006 Aug; 38(4):321-7. PubMed ID: 16916721
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients.
Cohen C; Alazraki N; Styblo T; Waldrop SM; Grant SF; Larsen T
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):296-303. PubMed ID: 12607596
[TBL] [Abstract][Full Text] [Related]
47. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
48. In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure.
van Deurzen CH; Borgstein PJ; van Diest PJ
J Clin Pathol; 2008 Dec; 61(12):1314-6. PubMed ID: 18794198
[TBL] [Abstract][Full Text] [Related]
49. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
Gauthier T; Fermeaux V; Mollard J; Aubard Y
Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
[TBL] [Abstract][Full Text] [Related]
50. [The relation between p53 expression and lymph node metastasis of breast cancer].
Chen YH; Cai JJ; Lu YD
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):266-8. PubMed ID: 7805554
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy.
Altgassen C; Müller N; Hornemann A; Kavallaris A; Hornung D; Diedrich K; Jarutat T
Gynecol Oncol; 2009 Aug; 114(2):284-7. PubMed ID: 19447478
[TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph nodes study: how to do it right? The Argentinean experience.
Allende D; Denninghoff V; Avagnina A; Elsner B
Breast J; 2008; 14(2):216-7. PubMed ID: 18248555
[No Abstract] [Full Text] [Related]
53. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
[TBL] [Abstract][Full Text] [Related]
54. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
55. PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer.
Zhu L; Loo WT; Louis WC
Biomed Pharmacother; 2007 Oct; 61(9):558-61. PubMed ID: 17919877
[TBL] [Abstract][Full Text] [Related]
56. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
57. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
58. Intramammary lymph node metastasis of breast cancer after sentinel node biopsy: two cases and a review of the literature.
Bats AS; Coutant C; Antoine M; Uzan S; Barranger E
Eur J Surg Oncol; 2009 Mar; 35(3):331-2. PubMed ID: 18479883
[No Abstract] [Full Text] [Related]
59. Pathological evaluation of sentinel lymph nodes.
Cserni G
Surg Oncol Clin N Am; 2007 Jan; 16(1):17-34. PubMed ID: 17336234
[TBL] [Abstract][Full Text] [Related]
60. Isolated tumor cells in sentinel lymph node and clinical implications for early breast cancer.
Ziogas D; Lykoudis EG; Zografos GC
Ann Surg Oncol; 2009 Sep; 16(9):2659-60; author reply 2661. PubMed ID: 19543773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
